Illustrative image – not actual.ALLERGAN
India (AIL), the joint venture between the US-based Allergan Inc and Nicholas
Piramal India, has plans to invest up to Rs 20 crore in Global Bulk Drugs and
Fine Chemicals to set up a manufacturing facility in areas of ophthalmic and
skin healthcare for AIL.
Global
Bulk Drugs and Fine Chemicals is Hyderabad-based bulk drugs manufacturer
belonging to the Piramal group.
